Brief: GeNeuro: Frontiers In Genetics Review Supports Role Of Hidden DNA Viruses In Neurological Disorders
11/07/2019 17:39
July 11 (Reuters) - GENEURO SA GNRO.PA :
* FRONTIERS IN GENETICS REVIEW SUPPORTS ROLE OF HIDDEN DNA
VIRUSES
IN NEUROLOGICAL DISORDERS
* GENEURO'S TEMELIMAB MOST ADVANCED DRUG CANDIDATE TARGETING
PATHOGENIC HERV
* HUMAN ENDOGENOUS RETROVIRUSES LINKED TO MS, TYPE 1
DIABETES,
ALS, SCHIZOPHRENIA
Source text for Eikon: ID:nBw2GgtVNa
Further company coverage: GNRO.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com;))
Recent news on Geneuro SA
See all newsBrief: Geneuro SA Postpones Publication Of Half-Yearly Financial Report
Brief: Geneuro SA Announces Extension Of Its Definitive Debt-Restructuring Moratorium
Brief: Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas
Brief: Geneuro Confirms Top-Line Results In Its Post-Covid Trial By End-June
Brief: Geneuro announces EUR 5 Mln private placement